Importance Patients with cutaneous lupus erythematosus (CLE) who develop systemic lupus
erythematosus (SLE) may have few and mild systemic symptoms. Objective To characterize …

In this prospective, cross-sectional, multicenter study, we assessed clinical and laboratory
characteristics from patients with cutaneous lupus erythematosus (CLE) using the Core Set …

Lupus erythematosus is an autoimmune disease that may manifest in a variety of organs
and tissues including the skin, kidney, brain, heart and lung. Many patients present with …

Objectives To assess trends in the cutaneous variants of lupus erythematosus (CLE) and to
ascertain the incidence of CLE over the past 4 decades. Design Retrospective population …

Background Studies reporting the incidence of isolated cutaneous lupus erythematosus
(CLE) are rare. Objectives To examine in a population‐based cohort study the incidence of …

Cutaneous lupus erythematosus (CLE) includes a broad range of dermatologic
manifestations, which may or may not be associated with systemic disease. Recent studies …

Objectives To assess disease severity in subsets of patients with cutaneous lupus
erythematosus (CLE) by using outcome and quality-of-life measures, and to determine …

Introduction Cutaneous manifestations are central to the primary diagnosis of systemic lupus
erythematosus (SLE). However, information on the clinical, histopathologic, and direct …

The majority of patients with systemic lupus erythematosus (SLE) have cutaneous
manifestations at some point in their disease course. The skin findings in SLE are classified …

The skin findings seen in lupus erythematosus can present with either lupus-specific or
lupus-nonspecific findings, with lupus-specific skin disease showing findings …